Once internalized by pancreatic cancer cells, the galectin-9 siRNA blocked the galectin-9/dectin-1 axis to enhance immunotherapy, and the OXA induced immunogenic tumor cell death. Here, LGALS9 is linked to pancreatic neoplasm.